Kitchens: CONSULTATIVE HEMOSTASIS & THROMBOSIS TOC PART 1: Hemorrhagic Processes 1. Consultative Process 2. An Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing 3. Hemophilia A and B 4. Less Common Congenital Disorders of Hemostasis 5. Acquired Coagulation Disorders Due to Inhibitors 6. von Willebrand Disease 7. General Aspects of Thrombocytopenia, Platelet Transfusions, and Thrombopoietic Growth Factors 8. Primary Immune Thrombocytopenia 9. Congenital and Acquired Disorders of Platelet Function and Number 10. Purpura and Other Hematovascular Disorders 11. HHT 12. Disseminated Intravascular Coagulation 13. The Cross-Talk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation PART 2: Thrombotic Processes 14. Thrombophilia: Clinical and Laboratory Assessment and Management 15. Pediatric Aspects of Thrombophilia 16. Deep Vein Thrombosis, Pulmonary Embolism and Primary Pulmonary Hypertension 17. Venous Thromboses at Unusual Sites 18. The Post Thrombotic Syndrome 19. Thrombocytosis: Essential Thrombocytemia and Reactive Causes 20. Antiphospholipid Syndrome 21. Antiplatelet Treatment in Cardiovascular Medicine 22. Non-Arteriosclerotic Arterial Occlusive Disease 23. Thrombosis and Cancer 24. Thrombotic Thrombocytopenic Purpura 25. Hemostatic Disorders of Complement Activation (PNH and aHUS) - New Chapter 26. Heparin-Induced Thrombocytopenia PART 3: Therapeutic Agents 27. Antithrombotic Agents 28. Blood Component and Pharmacological Agents 29. Therapeutic Apheresis âEUR Applications for Hemorrhagic & Thrombotic Disorders 30. Vena Caval Filters PART 4: Issues Specific to Women 31. Thrombotic Risk of Contraceptives and other Hormnal Therapies 32. Bleeding and the Management of Hemorrhagic Disorders in Pregnancy 33. Thrombophilia in Pregnancy PART 5: Special Issues 34. Surgery and Hemostasis 35. Anticoagulation in the Perioperative Period 36. Understanding and Managing the Coagulopathy of Liver Disease 37. Outpatient Anticoagulant Therapy38. Hematologic Interventions for Acute Central Nervous System Disease 39. Pending: Atrial Septal Abnormalties and Cryptogenic Stroke 40. Hemorrhage Control and Thrombosis Following Severe Injury 41. Hemostatic Aspects of Sickle Cell Disease Skryť popis